Freshfields Bruckhaus Deringer and K&L Gates assisted Mindray Netherlands’ EUR115 million (USD126 million) purchase of Gorka Holding’s 75% stake in German company DiaSys Diagnostic Systems.
Partner Olga Stürmer and principal associate Carsten Haak in Frankfurt, and partner Richard Perks in Hong Kong led the Freshfields team counselling Mindray Netherlands, a subsidiary of Chinese medical devices maker Mindray.
Freshfields partners Alastair Mordaunt in Hong Kong and Frank Röhling in Berlin provided antitrust and foreign investment advice, and partner Alexander Schwahn in Berlin advised on tax matters. Frankfurt-based partners Frank Schaer and Igor Gerber also provided support.
K&L Gates’ cross-practice team advising Gorka was led by Frankfurt-based partners Volker Gattringer and Boris Kläsener, with the support of corporate and M&A partners Kerstin Hanke in Frankfurt and Wilhelm Hartung in Berlin, IP partner Thorsten Vormann and tax partner Rainer Schmitt in Frankfurt, labour partner Nils Neumann and technology transactions partner Thomas Nietsch in Berlin, as well as antitrust, competition and trade regulation partners Annette Mutschler-Siebert in Berlin and Steven Hill from Washington.
Apart from the acquisition, Mindray Netherlands and Gorka will add EUR30 million and EUR10 million, respectively, to support business development at DiaSys. After the transaction, Mindray Netherlands will hold 75% of DiaSys and Gorka will have the remainder.
